Nan Fung Trinity (Hk) LTD Bristol Myers Squibb CO Transaction History

Nan Fung Trinity (Hk) LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $8.42 Million - $9.27 Million	-115,893 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$61.48 - $73.72 $13.5 Million - $16.2 Million	-219,200 Reduced 65.41%	115,893 $8.46 Million
Q4 2021 Jan 21, 2022	BUY	$53.63 - $62.52 $1.93 Million - $2.25 Million	36,000 Added 12.04%	335,093 $20.9 Million
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $6.22 Million - $6.78 Million	100,508 Added 50.61%	299,093 $20 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $2.93 Million - $3.3 Million	49,400 Added 33.11%	198,585 $12.5 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $4.66 Million - $5.28 Million	80,685 Added 117.79%	149,185 $9.25 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $3.18 Million - $4.62 Million	-68,500 Reduced 50.0%	68,500 $3.82 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $6.74 Million - $8.79 Million	137,000 New	137,000 $8.79 Million

2,407

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nan Fung Trinity (Hk) LTD, based on Form 13F filings with the SEC.

Stay updated on Nan Fung Trinity (Hk) LTD with notifications on news.